Liquid biopsy using extracellular vesicle–derived DNA in lung adenocarcinoma

Blood liquid biopsy has emerged as a way of overcoming the clinical limitations of repeat biopsy by testing for the presence of acquired resistance mutations to therapeutic agents. Despite its merits of repeatability and non-invasiveness, this method is currently only used as a supplemental test due...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, In Ae, Hur, Jae Young, Kim, Hee Joung, Lee, Seung Eun, Kim, Wan Seop, Lee, Kye Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pathologists and the Korean Society for Cytopathology 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674759/
https://www.ncbi.nlm.nih.gov/pubmed/33027851
http://dx.doi.org/10.4132/jptm.2020.08.13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674759/
https://www.ncbi.nlm.nih.gov/pubmed/33027851
http://dx.doi.org/10.4132/jptm.2020.08.13

Ejemplares similares